This talk will explore the evolving role of RTSM as more Pharma and Biotech companies of all sizes begin to realize the risks and inefficiencies associated with manual management of inventory, bulk batch genealogy and GMP / Release Activities. Enabled by the GS1 issuance of Clinical Trial Electronic Messaging Standards, the industry is experiencing a surge in adoption of enterprise-based supply chain solutions.
How does RTSM fit into the bigger picture and what does this ERP based model mean for RTSM?
How can we simplify the transition to this new model?
How can we optimize this new model to dramatically improve efficiencies across the end-to-end supply chain?